Virtual Event
-
Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors
Virtual Event
Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. In this workshop, FDA will convene a panel of external experts to